Clinical trials: Arterial Thromboembolic Event

Peripheral Arterial Disease, Venous Thormboembolism

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

• Recruiting
• Age: All ages
• Phase 4

Venous thromboembolism (VTE) has a high prevalence in patients with multiple comorbidities undergoing complex surgical procedures.

Conditions

Peripheral Arterial Disease, Venous Thormboembolism, Cardiovascular Diseases, Vascular Surgery Patient with PAD / Carotid Stenosis

Trial name

RESOLUTION (NCT06873321)

Testing

rivaroxaban 2.5 mg bid + aspirin 100 mg, clopidogrel 75 mg od for 3 months followed by aspirin 100 mg od for endovascular procedures or aspirin for open procedures

Where

Brazil

Volunteers

100 people

Sponsor

Science Valley Research Institute